MedicaidPrior AuthMedium impact
BT202325: Pharmacy updates approved by Drug Utilization Review Board March 2023
Indiana Medicaid (IHCP)·IN · Endocrinology, Family Medicine, Internal Medicine·Prior Authorization
Effective date
May 1, 2023
We identified it
Jun 19, 2026
Summary
Indiana Medicaid updated prior authorization criteria for GLP-1 receptor agonists and non-PDL agents, enhanced their automated SilentAuth system, and made changes to the Preferred Drug List including making insulin glargine preferred and removing Voltaren gel from the PDL.
Action Required
By May 1, 2023: Billing team must review updated prior authorization criteria for GLP-1 receptor agonists and non-PDL agents on the Optum Rx Indiana Medicaid website. Update billing system to reflect insulin glargine as preferred and Voltaren gel removal from PDL. Contact Optum Rx Clinical and Technical Help Desk at 855-577-6317 for PA requests and questions.